Form 4 for KYNB KYNTRA BIO, INC.
Accepted 2024-02-05 00:00:00 ET · period of report 2024-02-01 · accession 0001415889-24-002750 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-05 | 2024-02-01 | KYNB | Wettig Thane | CEO | F - Tax | $2.37 | -23.5K | 257.9K | -8% | -$55.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-01 | F | D | 23,490 | $2.37 | 257,932 | D | — | — | (F1) Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. |